Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study

• Felix R. Kayigamba ,

  * E-mail: fkaigamba@gmail.com

  Affiliation INTERACT, CPCD, PO Box 2181, Kigali, Rwanda

  ⨯
• Molly F. Franke,

  Affiliations Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America, Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda

  ⨯
• Mirjam I. Bakker,

  Affiliation Royal Tropical Institute, KIT Biomedical Research, Amsterdam, the Netherlands

  ⨯
• Carly A. Rodriguez,

  Affiliation Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America

  ⨯
• Emmanuel Bagiruwigize,

  Affiliation INTERACT, CPCD, PO Box 2181, Kigali, Rwanda

  ⨯
• Ferdinand WNM Wit,

  Affiliations Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, the Netherlands, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, the Netherlands

  ⨯
• Michael L. Rich,

  Affiliations Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda, Division of Global Health Equity, Brigham and Women’s Hospital, Boston, MA, United States of America

  ⨯
• Maarten F. Schim van der Loeff

  Affiliations Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, the Netherlands, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, the Netherlands, Public Health Service of Amsterdam (GGD), Amsterdam, the Netherlands

  ⨯